Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03102060 · ClinicalTrials.gov registry record · NA
Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03102060 is a NA study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 7 participants.
The verdict
NCT03102060, a NA study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well a gluten free diet works in preventing graft versus host disease in patients who are undergoing a donor stem cell transplant. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells (called graft versus host disease). A gluten free diet may decrease intestinal inflammation and graft versus host disease in patients who are undergoing a donor stem cell transplant.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Dietary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-08-22 |
| Est. Completion | 2018-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03102060
The ClinicalTrials.gov registry entry for NCT03102060 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03102060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03102060 about?
NCT03102060 is a clinical study titled "Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant". This pilot clinical trial studies how well a gluten free diet works in preventing graft versus host disease in patients who are undergoing a donor stem cell transplant. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells (called graft versus host...
What is the current status of trial NCT03102060?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2017-08-22. Estimated completion is 2018-06-11.
What interventions are being tested in trial NCT03102060?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Dietary Intervention (OTHER).
Who is sponsoring clinical trial NCT03102060?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.